Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
3(21%)
Results Posted
50%(2 trials)
Terminated
2(14%)

Phase Distribution

Ph not_applicable
5
36%
Ph phase_2
5
36%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
5(45.5%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Recruiting3
Not yet recruiting3
Terminated2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (9.1%)
Phase 25 (45.5%)
N/A5 (45.5%)

Trials by Status

recruiting321%
terminated214%
unknown17%
completed429%
withdrawn17%
not_yet_recruiting321%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT05660421Phase 2

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Withdrawn
NCT06386315Phase 2

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Recruiting
NCT07405476Phase 2

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Recruiting
NCT07206589Not Applicable

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Not Yet Recruiting
NCT06732388Phase 2

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Not Yet Recruiting
NCT03819296Phase 1

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Recruiting
NCT06587633Not Applicable

3D BIO-STRUCTURES FOR G.I. POST-SURGICAL DEFECTS

Not Yet Recruiting
NCT04880538

Enteric Neural Precursor Cells (ENPC) in the Human Gut

Completed
NCT02560623Not Applicable

A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

Completed
NCT04598256

Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic

Completed
NCT01164566Not Applicable

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Terminated
NCT02734316

Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures

Completed
NCT00987857Not Applicable

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Unknown
NCT00528775Phase 2

Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages

Terminated

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14